1-3 of 3
Gabriella Zupi
Close
Sort by
Journal Articles

Comparative Gene Profiling of Acute Myeloid Leukemia (AML) and Malignant Melanoma (MEL) Cell Lines Exposed to the MEK Inhibitor PD0325901 Reveals Common Effectors of the MEK/ERK Kinase Module.

Michele Milella, MD, Sabina Chiaretti, MD, PhD, Maria R. Ricciardi, PhD, Simona Tavolaro, BSc, Ludovica Ciuffreda, PhD, Barbara Benassi, PhD, Alfonso Bellacosa, MD, PhD, Gianfranco Peluso, PhD, Paola Bergamo, MS, James A. McCubrey, PhD, Francesco Cognetti, MD, Gabriella Zupi, PhD, Robert Foà, MD, Agostino Tafuri, MD
Journal: Blood
Blood (2007) 110 (11): 3470.
https://doi.org/10.1182/blood.V110.11.3470.3470
Published: 2007
Journal Articles

Effective Targeting of MEK/ERK Signalling at Nanomolar Concentrations by the Novel Small Molecule Inhibitor PD0325901 in Hematopoietic and Solid Tumors.

Maria R. Ricciardi, PhD, Maria C. Scerpa, PhD, Ludovica Ciuffreda, PhD, Sabina Chiaretti, MD, PhD, Simona Tavolaro, PhD, Jacopo Gervasoni, Fabiana De Cave, PhD, Chiara Gregorj, PhD, Maria T. Petrucci, MD, Francesco Cognetti, MD, Michael Andreeff, MD, PhD, Gabriella Zupi, MD, Robin Foà, MD, Agostino Tafuri, MD, Michele Milella, MD
Journal: Blood
Blood (2005) 106 (11): 3370.
https://doi.org/10.1182/blood.V106.11.3370.3370
Published: 2005
Journal Articles

Combined treatment with temozolomide and poly(ADP-ribose) polymerase inhibitor enhances survival of mice bearing hematologic malignancy at the central nervous system site

Brief Report
Lucio Tentori, Carlo Leonetti, Marco Scarsella, Giulia d'Amati, Ilaria Portarena, Gabriella Zupi, Enzo Bonmassar, Grazia Graziani
Journal: Blood
Blood (2002) 99 (6): 2241–2244.
https://doi.org/10.1182/blood.V99.6.2241
Published: 2002